Featured Post

Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia

Image
infection in lungs is it dangerous :: Article Creator Transplanted Lungs Likely Spread Dangerous Legionella Infection To Two Recipients, Study Says - CNN CNN  —  For the first time, an organ transplant is believed to have spread dangerous Legionella bacteria, according to a report published Thursday by the US Centers for Disease Control and Prevention. The two people who developed Legionnaires' disease received donated lungs from a man who died last year after falling into a river in Pennsylvania. The man, who was in his 30s, had been declared brain-dead after attempts to resuscitate him were unsuccessful. Polish authorities probe whether deadly Legionnaires' outbreak was result of water tampering Doctors were able to transplant his right lung into a woman in her 70s. His left lung went to a man in his 60s. Both eventually developed Legionnaires', a severe form of pneumonia caused by the Legionella bacteria. People who re...

Coronavirus & COVID-19 Overview: Symptoms, Risks, Prevention, Treatment & More



malignant neoplasm of lung :: Article Creator

List Of Drugs That May Cause 'Malignant Lung Neoplasm' - Medindia

Acitretin , Copolymer , Deprenyl , Docetaxel , Doxazosin , Formoterol , Glat , Insulin , Mirabegron , Mycophenolate , Olodaterol , Pergolide , Pramipexole , Pregabalin , Procarbazine , Rabeprazole , Rifapentine , Riluzole , Roflumilast , Sildenafil , Topotecan , Valdecoxib , Vinorelbine Find drugs that can cause other symptoms like 'Malignant Lung Neoplasm' References
  • https://www.Fda.Gov/drugs/information-consumers-and-patients-drugs/finding-and-learning-about-side-effects-adverse-reactions
  • https://nctr-crs.Fda.Gov/fdalabel/ui/search
  • https://dailymed.Nlm.Nih.Gov/dailymed/

  • High Incidence Of Secondary Malignant Neoplasms Observed Among Young Sarcoma Survivors

    February 01, 2023

    1 min read

    Add topic to email alerts

    Receive an email when new articles are posted on

    Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.Com.

    Back to Healio

    Childhood, adolescent and young adult survivors of bone and soft tissue sarcomas had an increased risk for second malignant neoplasms, according to study results in Cancer.

    The findings indicate a need for lifelong follow-up and effective aftercare for this patient population, researchers noted.

    Fibrosarcoma, malignant tumor of fibroblasts, one of soft tissue sarcomas, light micrograph, photo under microscopeSource: Adobe Stock. Rationale and methods

    "The challenge of modern cancer therapy is still to cure but also to prevent late effects, especially in children, adolescents and young adults for whom the perspective of an adequate quality of life is a prerequisite of management," Stefanie J. Kube, MD, researcher in the department of pediatrics at Klinikum Stuttgart Olgahospital in Germany, and colleagues wrote.

    Investigators sought to assess incidence of second malignant neoplasms, as well as latency, histiotype and outcome, among 7,079 young survivors of sarcoma (median age at diagnosis, 17.5 years) included in clinical trials or in registries with a primary sarcoma. Researchers used descriptive analysis, the Kaplan-Meier method, and the Gray, Fine-Gray and Cox regression models for statistical analyses.

    Key findings

    Overall, 159 (2.2%) patients had a recorded second malignant neoplasm, of which researchers noted 104 (65%) solid second malignant neoplasms and 56 (35%) hematologic second malignant neoplasms. Median age at diagnosis of second malignant neoplasm was 17.5 years (range, 2.1-43.4).

    Median time from first diagnosis of sarcoma to the diagnosis of second malignant neoplasm was 6.8 years, and researchers found a cumulative incidence of second malignant neoplasm of 8.8% after 30 years.

    Moreover, all patients had a 5-year survival rate of 67.1% (95% CI, 66-68.2) compared with 45.1% (95% CI, 36.2-53.6) after the second malignant neoplasm diagnosis among the subcohort of 159 patients.

    Implications

    "There is a remarkable high cumulative incidence of second malignant neoplasms after bone and soft tissue sarcomas in children, adolescents and young adults. Therefore, effective transition, as well as risk adapted long-term follow-up care programs, should be developed and offered to young sarcoma survivors," Kube and colleagues wrote. "Our findings provide a basis to counsel young sarcoma survivors on their individual risk [for] subsequent malignant tumors. Moreover, these data can help to establish recommendations for aftercare in young sarcoma survivors."

    Sources/DisclosuresCollapse Disclosures: Deutsche Forschungsgemeinschaft, Deutsche Kinderkrebsstiftung, Federal Ministry of Research and Technology, Foerdergemeinschaft Kinderkrebszentrum Hamburg, Foerderkreis Krebskranke Kinder Stuttgart and the German Cancer Aid Foundation supported the study. Kube reports no relevant financial disclosures. Please see the study for all authors' relevant financial disclosures.

    Add topic to email alerts

    Receive an email when new articles are posted on

    Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.Com.

    Back to Healio






    Comments

    Popular Posts

    Model Monday's: Diana Moldovan

    “Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University” plus 1 more

    Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University